Home › Chronic Lymphocytic Leukemia › Florida › Miami
Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Miami, FL
9 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Miami (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Nagre-recruitPhase 3
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
Nagre-recruitPhase 3
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Nagre-recruitPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Nagre-recruitPhase 1
- University of Miami, Miami
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Nagre-recruitPhase 2
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Nagre-recruitPhase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Nagre-recruitPhase 4
- Sylvester Comprehensive Cancer Center, Miami
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Nagre-recruitPhase 4
- Sylvester Comprehensive Cancer Center, Miami
Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod
- Boston, MA32 pag-aaral
- Columbus, OH29 pag-aaral
- Durham, NC27 pag-aaral
- Washington, DC22 pag-aaral
- Seattle, WA21 pag-aaral
- Rochester, MN19 pag-aaral
- New York City, NY18 pag-aaral
- Houston, TX17 pag-aaral
- Baldwin Park, CA16 pag-aaral
- Milwaukee, WI14 pag-aaral
- Chicago, IL14 pag-aaral
- Cincinnati, OH14 pag-aaral
Iba pang pag-aaral sa Miami
- Kanser sa Suso42 pag-aaral
- Kanser (lahat ng uri)36 pag-aaral
- Non-Small Cell Lung Cancer31 pag-aaral
- Kanser sa Prostate28 pag-aaral
- Obesity27 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Overweight23 pag-aaral
- Kanser sa Ovary23 pag-aaral
- Metastatic Cancer23 pag-aaral
- Ulcerative Colitis22 pag-aaral
- Sakit ni Alzheimer21 pag-aaral
- Multiple Myeloma21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Set 29, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.